Multicopy Suppressors for Novel Antibacterial Compounds Reveal Targets and Drug Efflux Susceptibility

Gene dosage has frequently been exploited to select for genetic interactions between a particular mutant and clones from a random genomic library at high copy. We report here the first use of multicopy suppression as a forward genetic method to determine cellular targets and potential resistance mec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chemistry & biology 2004-10, Vol.11 (10), p.1423-1430
Hauptverfasser: Li, Xiaoming, Zolli-Juran, Michela, Cechetto, Jonathan D., Daigle, Denis M., Wright, Gerard D., Brown, Eric D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1430
container_issue 10
container_start_page 1423
container_title Chemistry & biology
container_volume 11
creator Li, Xiaoming
Zolli-Juran, Michela
Cechetto, Jonathan D.
Daigle, Denis M.
Wright, Gerard D.
Brown, Eric D.
description Gene dosage has frequently been exploited to select for genetic interactions between a particular mutant and clones from a random genomic library at high copy. We report here the first use of multicopy suppression as a forward genetic method to determine cellular targets and potential resistance mechanisms for novel antibacterial compounds identified through high-throughput screening. A screen of 8640 small molecules for growth inhibition of a hyperpermeable strain of Escherichia coli led to the identification of 49 leads for suppressor selection from clones harboring an E. coli genomic library. The majority of suppressors were found to encode the multidrug efflux pump AcrB, indicating that those compounds were substrates for efflux. Two leads, which produced clones containing the gene folA, encoding dihydrofolate reductase (DHFR), proved to target DHFR in vivo and were competitive inhibitors in vitro.
doi_str_mv 10.1016/j.chembiol.2004.08.014
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66976618</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1074552104002492</els_id><sourcerecordid>66976618</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-7eb6f409735f95917dcd8e4dd7e658a3ae4596a203cac826a4c4b949729a19163</originalsourceid><addsrcrecordid>eNqFkctO3DAUhq2KqlzKKyCv2CW1E8exd6DhUiSgUgtry7FPwCMnDnYyYt6-RjNVl6zO0dH3n9uP0BklJSWU_1iX5hWGzgVfVoSwkoiSUPYFHVHRyoLWhB7knLSsaJqKHqLjlNaEECok_4YOacOEpFweIXhY_OxMmLb4zzJNEVIKMeE-RPwYNuDx5Ti7TpsZotMer8IwhWW0Cf-GDeTCk44vMCesR4uv4vKCr_veL--5WTIwZanzbt5-R1977ROc7uMJer65flr9LO5_3d6tLu8Lw1g9Fy10vGdEtnXTy0bS1horgFnbAm-ErjWwRnJdkdpoIyqumWGdZLKtpKb5nvoEne_6TjG8LZBmNbi8h_d6hLAkxblsOafiU5BKSZuqrjLId6CJIaUIvZqiG3TcKkrUhxNqrf45oT6cUESo7EQWnu0nLN0A9r9s__oMXOwAyA_ZOIgqGQejAesimFnZ4D6b8Reg0567</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19915232</pqid></control><display><type>article</type><title>Multicopy Suppressors for Novel Antibacterial Compounds Reveal Targets and Drug Efflux Susceptibility</title><source>MEDLINE</source><source>Cell Press Free Archives</source><source>Access via ScienceDirect (Elsevier)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Li, Xiaoming ; Zolli-Juran, Michela ; Cechetto, Jonathan D. ; Daigle, Denis M. ; Wright, Gerard D. ; Brown, Eric D.</creator><creatorcontrib>Li, Xiaoming ; Zolli-Juran, Michela ; Cechetto, Jonathan D. ; Daigle, Denis M. ; Wright, Gerard D. ; Brown, Eric D.</creatorcontrib><description>Gene dosage has frequently been exploited to select for genetic interactions between a particular mutant and clones from a random genomic library at high copy. We report here the first use of multicopy suppression as a forward genetic method to determine cellular targets and potential resistance mechanisms for novel antibacterial compounds identified through high-throughput screening. A screen of 8640 small molecules for growth inhibition of a hyperpermeable strain of Escherichia coli led to the identification of 49 leads for suppressor selection from clones harboring an E. coli genomic library. The majority of suppressors were found to encode the multidrug efflux pump AcrB, indicating that those compounds were substrates for efflux. Two leads, which produced clones containing the gene folA, encoding dihydrofolate reductase (DHFR), proved to target DHFR in vivo and were competitive inhibitors in vitro.</description><identifier>ISSN: 1074-5521</identifier><identifier>EISSN: 1879-1301</identifier><identifier>DOI: 10.1016/j.chembiol.2004.08.014</identifier><identifier>PMID: 15489169</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Anti-Bacterial Agents - administration &amp; dosage ; Anti-Bacterial Agents - chemistry ; Drug Delivery Systems - methods ; Drug Resistance, Bacterial - genetics ; Escherichia coli ; Escherichia coli - drug effects ; Escherichia coli - enzymology ; Escherichia coli - genetics ; Escherichia coli - growth &amp; development ; Gene Dosage ; Genome, Bacterial ; Genomic Library ; Growth Inhibitors - administration &amp; dosage ; Growth Inhibitors - chemistry ; Microbial Sensitivity Tests - statistics &amp; numerical data ; Tetrahydrofolate Dehydrogenase - biosynthesis ; Tetrahydrofolate Dehydrogenase - physiology</subject><ispartof>Chemistry &amp; biology, 2004-10, Vol.11 (10), p.1423-1430</ispartof><rights>2004 Elsevier Ltd</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c443t-7eb6f409735f95917dcd8e4dd7e658a3ae4596a203cac826a4c4b949729a19163</citedby><cites>FETCH-LOGICAL-c443t-7eb6f409735f95917dcd8e4dd7e658a3ae4596a203cac826a4c4b949729a19163</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.chembiol.2004.08.014$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>315,782,786,3554,27933,27934,46004</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15489169$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Xiaoming</creatorcontrib><creatorcontrib>Zolli-Juran, Michela</creatorcontrib><creatorcontrib>Cechetto, Jonathan D.</creatorcontrib><creatorcontrib>Daigle, Denis M.</creatorcontrib><creatorcontrib>Wright, Gerard D.</creatorcontrib><creatorcontrib>Brown, Eric D.</creatorcontrib><title>Multicopy Suppressors for Novel Antibacterial Compounds Reveal Targets and Drug Efflux Susceptibility</title><title>Chemistry &amp; biology</title><addtitle>Chem Biol</addtitle><description>Gene dosage has frequently been exploited to select for genetic interactions between a particular mutant and clones from a random genomic library at high copy. We report here the first use of multicopy suppression as a forward genetic method to determine cellular targets and potential resistance mechanisms for novel antibacterial compounds identified through high-throughput screening. A screen of 8640 small molecules for growth inhibition of a hyperpermeable strain of Escherichia coli led to the identification of 49 leads for suppressor selection from clones harboring an E. coli genomic library. The majority of suppressors were found to encode the multidrug efflux pump AcrB, indicating that those compounds were substrates for efflux. Two leads, which produced clones containing the gene folA, encoding dihydrofolate reductase (DHFR), proved to target DHFR in vivo and were competitive inhibitors in vitro.</description><subject>Anti-Bacterial Agents - administration &amp; dosage</subject><subject>Anti-Bacterial Agents - chemistry</subject><subject>Drug Delivery Systems - methods</subject><subject>Drug Resistance, Bacterial - genetics</subject><subject>Escherichia coli</subject><subject>Escherichia coli - drug effects</subject><subject>Escherichia coli - enzymology</subject><subject>Escherichia coli - genetics</subject><subject>Escherichia coli - growth &amp; development</subject><subject>Gene Dosage</subject><subject>Genome, Bacterial</subject><subject>Genomic Library</subject><subject>Growth Inhibitors - administration &amp; dosage</subject><subject>Growth Inhibitors - chemistry</subject><subject>Microbial Sensitivity Tests - statistics &amp; numerical data</subject><subject>Tetrahydrofolate Dehydrogenase - biosynthesis</subject><subject>Tetrahydrofolate Dehydrogenase - physiology</subject><issn>1074-5521</issn><issn>1879-1301</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkctO3DAUhq2KqlzKKyCv2CW1E8exd6DhUiSgUgtry7FPwCMnDnYyYt6-RjNVl6zO0dH3n9uP0BklJSWU_1iX5hWGzgVfVoSwkoiSUPYFHVHRyoLWhB7knLSsaJqKHqLjlNaEECok_4YOacOEpFweIXhY_OxMmLb4zzJNEVIKMeE-RPwYNuDx5Ti7TpsZotMer8IwhWW0Cf-GDeTCk44vMCesR4uv4vKCr_veL--5WTIwZanzbt5-R1977ROc7uMJer65flr9LO5_3d6tLu8Lw1g9Fy10vGdEtnXTy0bS1horgFnbAm-ErjWwRnJdkdpoIyqumWGdZLKtpKb5nvoEne_6TjG8LZBmNbi8h_d6hLAkxblsOafiU5BKSZuqrjLId6CJIaUIvZqiG3TcKkrUhxNqrf45oT6cUESo7EQWnu0nLN0A9r9s__oMXOwAyA_ZOIgqGQejAesimFnZ4D6b8Reg0567</recordid><startdate>20041001</startdate><enddate>20041001</enddate><creator>Li, Xiaoming</creator><creator>Zolli-Juran, Michela</creator><creator>Cechetto, Jonathan D.</creator><creator>Daigle, Denis M.</creator><creator>Wright, Gerard D.</creator><creator>Brown, Eric D.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20041001</creationdate><title>Multicopy Suppressors for Novel Antibacterial Compounds Reveal Targets and Drug Efflux Susceptibility</title><author>Li, Xiaoming ; Zolli-Juran, Michela ; Cechetto, Jonathan D. ; Daigle, Denis M. ; Wright, Gerard D. ; Brown, Eric D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-7eb6f409735f95917dcd8e4dd7e658a3ae4596a203cac826a4c4b949729a19163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Anti-Bacterial Agents - administration &amp; dosage</topic><topic>Anti-Bacterial Agents - chemistry</topic><topic>Drug Delivery Systems - methods</topic><topic>Drug Resistance, Bacterial - genetics</topic><topic>Escherichia coli</topic><topic>Escherichia coli - drug effects</topic><topic>Escherichia coli - enzymology</topic><topic>Escherichia coli - genetics</topic><topic>Escherichia coli - growth &amp; development</topic><topic>Gene Dosage</topic><topic>Genome, Bacterial</topic><topic>Genomic Library</topic><topic>Growth Inhibitors - administration &amp; dosage</topic><topic>Growth Inhibitors - chemistry</topic><topic>Microbial Sensitivity Tests - statistics &amp; numerical data</topic><topic>Tetrahydrofolate Dehydrogenase - biosynthesis</topic><topic>Tetrahydrofolate Dehydrogenase - physiology</topic><toplevel>online_resources</toplevel><creatorcontrib>Li, Xiaoming</creatorcontrib><creatorcontrib>Zolli-Juran, Michela</creatorcontrib><creatorcontrib>Cechetto, Jonathan D.</creatorcontrib><creatorcontrib>Daigle, Denis M.</creatorcontrib><creatorcontrib>Wright, Gerard D.</creatorcontrib><creatorcontrib>Brown, Eric D.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Chemistry &amp; biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Xiaoming</au><au>Zolli-Juran, Michela</au><au>Cechetto, Jonathan D.</au><au>Daigle, Denis M.</au><au>Wright, Gerard D.</au><au>Brown, Eric D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multicopy Suppressors for Novel Antibacterial Compounds Reveal Targets and Drug Efflux Susceptibility</atitle><jtitle>Chemistry &amp; biology</jtitle><addtitle>Chem Biol</addtitle><date>2004-10-01</date><risdate>2004</risdate><volume>11</volume><issue>10</issue><spage>1423</spage><epage>1430</epage><pages>1423-1430</pages><issn>1074-5521</issn><eissn>1879-1301</eissn><abstract>Gene dosage has frequently been exploited to select for genetic interactions between a particular mutant and clones from a random genomic library at high copy. We report here the first use of multicopy suppression as a forward genetic method to determine cellular targets and potential resistance mechanisms for novel antibacterial compounds identified through high-throughput screening. A screen of 8640 small molecules for growth inhibition of a hyperpermeable strain of Escherichia coli led to the identification of 49 leads for suppressor selection from clones harboring an E. coli genomic library. The majority of suppressors were found to encode the multidrug efflux pump AcrB, indicating that those compounds were substrates for efflux. Two leads, which produced clones containing the gene folA, encoding dihydrofolate reductase (DHFR), proved to target DHFR in vivo and were competitive inhibitors in vitro.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>15489169</pmid><doi>10.1016/j.chembiol.2004.08.014</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1074-5521
ispartof Chemistry & biology, 2004-10, Vol.11 (10), p.1423-1430
issn 1074-5521
1879-1301
language eng
recordid cdi_proquest_miscellaneous_66976618
source MEDLINE; Cell Press Free Archives; Access via ScienceDirect (Elsevier); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Free Full-Text Journals in Chemistry
subjects Anti-Bacterial Agents - administration & dosage
Anti-Bacterial Agents - chemistry
Drug Delivery Systems - methods
Drug Resistance, Bacterial - genetics
Escherichia coli
Escherichia coli - drug effects
Escherichia coli - enzymology
Escherichia coli - genetics
Escherichia coli - growth & development
Gene Dosage
Genome, Bacterial
Genomic Library
Growth Inhibitors - administration & dosage
Growth Inhibitors - chemistry
Microbial Sensitivity Tests - statistics & numerical data
Tetrahydrofolate Dehydrogenase - biosynthesis
Tetrahydrofolate Dehydrogenase - physiology
title Multicopy Suppressors for Novel Antibacterial Compounds Reveal Targets and Drug Efflux Susceptibility
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-28T23%3A30%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multicopy%20Suppressors%20for%20Novel%20Antibacterial%20Compounds%20Reveal%20Targets%20and%20Drug%20Efflux%20Susceptibility&rft.jtitle=Chemistry%20&%20biology&rft.au=Li,%20Xiaoming&rft.date=2004-10-01&rft.volume=11&rft.issue=10&rft.spage=1423&rft.epage=1430&rft.pages=1423-1430&rft.issn=1074-5521&rft.eissn=1879-1301&rft_id=info:doi/10.1016/j.chembiol.2004.08.014&rft_dat=%3Cproquest_cross%3E66976618%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19915232&rft_id=info:pmid/15489169&rft_els_id=S1074552104002492&rfr_iscdi=true